• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者罗库溴铵剂量降低可缩短神经肌肉恢复时间。

Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients.

机构信息

Department of Anaesthesiology, Centre of Head and Orthopaedics, Section 6011, Copenhagen University Hospital - Rigshospitalet, Denmark.

出版信息

Dan Med J. 2024 May 13;71(6):A09230578. doi: 10.61409/A09230578.

DOI:10.61409/A09230578
PMID:38847412
Abstract

INTRODUCTION

The effect of neuromuscular blocking agents may be reversed by administration of neostigmine, when two twitches are present using train-of-four (TOF) stimulation. However, in elderly patients, limited data are available about when to administer neostigmine. We hypothesised that time to two twitches after TOF (TOF-2) was shorter after rocuronium 0.6 mg/kg than after rocuronium 0.9 mg/kg. Also, we hypothesised that time to TOF-2 would be shorter after rocuronium 0.3 mg/kg than after rocuronium 0.6 mg/kg.

METHODS

This was a secondary analysis of 50 elderly patients > 80 years; 16 patients received rocuronium 0.6 mg/kg, another 16 patients received rocuronium 0.9 mg/kg; and, finally, 18 patients received rocuronium 0.3 mg/kg. Patients received total intravenous anaesthesia, and neuromuscular block was monitored with acceleromyography.

RESULTS

Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after rocuronium 0.9 mg/kg: 37 min. versus 59 min. (difference: 22 min. (95% confidence intervals (CI): 10 to 33 min.), p = 0.0007). Time to TOF-2 after rocuronium 0.3 mg/kg was shorter than after rocuronium 0.6 mg/kg: 19 min. versus 37 min. (difference: 18 min. (95% CI: 11 to 25 min.), p = 0.00006). However, only 33% of the patients receiving 0.3 mg/kg obtained full effect i.e. TOF-0.

CONCLUSION

Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after 0.9 mg/kg and shorter after rocuronium 0.3 mg/kg than after 0.6 mg/kg.

FUNDING

This work was supported by departmental sources.

TRIAL REGISTRATION

This study was a secondary analysis of two clinical trials.

CLINICALTRIALS

gov (NCT04512313), (NCT03857750).

摘要

简介

当使用四脉冲刺激(TOF)时,存在两个抽搐时,给予新斯的明可逆转神经肌肉阻滞剂的作用。然而,在老年患者中,关于何时给予新斯的明的数据有限。我们假设,TOF 后出现两个抽搐的时间(TOF-2)在罗库溴铵 0.6mg/kg 时比罗库溴铵 0.9mg/kg 时更短。此外,我们假设,TOF-2 的时间在罗库溴铵 0.3mg/kg 时比罗库溴铵 0.6mg/kg 时更短。

方法

这是对 50 名年龄大于 80 岁的老年患者的二次分析;16 名患者接受罗库溴铵 0.6mg/kg,另 16 名患者接受罗库溴铵 0.9mg/kg,最后 18 名患者接受罗库溴铵 0.3mg/kg。患者接受全静脉麻醉,肌电图监测神经肌肉阻滞。

结果

罗库溴铵 0.6mg/kg 时 TOF-2 的时间短于罗库溴铵 0.9mg/kg:37min 与 59min(差异:22min(95%置信区间(CI):10-33min),p=0.0007)。罗库溴铵 0.3mg/kg 时 TOF-2 的时间短于罗库溴铵 0.6mg/kg:19min 与 37min(差异:18min(95%CI:11-25min),p=0.00006)。然而,只有 33%接受 0.3mg/kg 的患者获得完全效果,即 TOF-0。

结论

罗库溴铵 0.6mg/kg 时 TOF-2 的时间短于 0.9mg/kg,罗库溴铵 0.3mg/kg 时短于 0.6mg/kg。

基金

这项工作得到了部门来源的支持。

试验注册

这项研究是两项临床试验的二次分析。

临床试验

gov(NCT04512313),(NCT03857750)。

相似文献

1
Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients.老年患者罗库溴铵剂量降低可缩短神经肌肉恢复时间。
Dan Med J. 2024 May 13;71(6):A09230578. doi: 10.61409/A09230578.
2
[Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].[新斯的明对罗库溴铵或顺式阿曲库铵神经肌肉阻滞过程的影响:一项随机双盲试验]
Rev Esp Anestesiol Reanim. 2007 Aug-Sep;54(7):399-404.
3
Efficiency of the TOF-Cuff™ for the evaluation of rocuronium-induced neuromuscular block and its reversal with sugammadex: a comparative study vs. acceleromyography.TOF-Cuff™ 在评估罗库溴铵诱导的神经肌肉阻滞及其用 sugammadex 逆转中的效率:与肌电图描记法的比较研究。
J Anesth. 2019 Feb;33(1):80-84. doi: 10.1007/s00540-018-2587-4. Epub 2018 Nov 24.
4
Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.低剂量新斯的明用于拮抗吸入麻醉期间浅度阿曲库铵神经肌肉阻滞:一项随机对照试验。
Eur J Anaesthesiol. 2013 Oct;30(10):594-8. doi: 10.1097/EJA.0b013e3283631652.
5
Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgery.术中使用 sugammadex 或新斯的明逆转极外侧椎间融合术中的神经肌肉阻滞,一种脊柱外科新技术。
J Anesth. 2011 Oct;25(5):716-20. doi: 10.1007/s00540-011-1209-1. Epub 2011 Aug 13.
6
Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.舒更葡糖钠逆转罗库溴铵和维库溴铵诱发神经肌肉阻滞的疗效:26 项研究的汇总分析。
J Clin Anesth. 2017 Sep;41:84-91. doi: 10.1016/j.jclinane.2017.06.006. Epub 2017 Jul 15.
7
Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.新斯的明拮抗罗库溴铵诱导的儿童和成人神经肌肉阻滞的剂量-反应关系。
Br J Anaesth. 1996 Dec;77(6):710-5. doi: 10.1093/bja/77.6.710.
8
Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.舒更葡糖钠逆转罗库溴铵诱导的神经肌肉阻滞:与新斯的明-格隆溴铵及依酚氯铵-阿托品的比较
Anesth Analg. 2007 Mar;104(3):569-74. doi: 10.1213/01.ane.0000248224.42707.48.
9
Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.舒更葡糖钠用于终末期肾病患者罗库溴铵所致深度神经肌肉阻滞逆转的有效性和安全性:一项对比性前瞻性临床试验
Eur J Anaesthesiol. 2015 Oct;32(10):681-6. doi: 10.1097/EJA.0000000000000312.
10
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-Based Neurointerventional Procedures: A Randomized Trial.舒更葡糖钠与新斯的明用于导管介入神经治疗患者罗库溴铵神经肌肉阻滞逆转的随机试验
Anesth Analg. 2021 Jun 1;132(6):1666-1676. doi: 10.1213/ANE.0000000000005533.